Skip to main content
Premium Trial:

Request an Annual Quote

Base4 Becomes Exclusive Vendor of Open Text's Livelink R&D Technology

Premium

TORONTO--Base4 Bioinfor-matics announced that it has signed an agreement with Open Text to be the exclusive vendor of Open Text's Livelink technology to the Canadian and US R&D divisions of companies in the pharmaceutical sector. This technology is incorporated in Base4's PharMatrix software suite for pharmaceutical R&D project management. "The international, collaborative, high risk, and long time-frame characteristics of modern drug discovery have made electronic project management essential," said Martin Sumner-Smith, president of Base4. Base4 will maintain non-exclusive sales rights to all other companies and organizations in its target market.

Filed under

The Scan

Fertility Fraud Found

Consumer genetic testing has uncovered cases of fertility fraud that are leading to lawsuits, according to USA Today.

Ties Between Vigorous Exercise, ALS in Genetically At-Risk People

Regular strenuous exercise could contribute to motor neuron disease development among those already at genetic risk, Sky News reports.

Test Warning

The Guardian writes that the US regulators have warned against using a rapid COVID-19 test that is a key part of mass testing in the UK.

Science Papers Examine Feedback Mechanism Affecting Xist, Continuous Health Monitoring for Precision Medicine

In Science this week: analysis of cis confinement of the X-inactive specific transcript, and more.